INTRODUCTION
An estimated 36.7 million people are living with HIV worldwide [1] , of which approximately 145,000 live in Spain [2] . Improvements in antiretroviral therapy (ART) have led to increased life expectancy for many people living with HIV. In the last 2 decades, HIV infection has changed from a subacute infection with a high mortality rate to a chronic manageable infection. As a consequence, there has been a gradual increase in the number of aging people living with HIV [3] . In 2016, 46.3% of people living with HIV in Spain were C 50 years of age [4, 5] . In this scenario, AIDS-defining illnesses have lost their leading role and have been displaced by the different comorbidities related to age and the geriatric syndromes themselves [4] . However, several HIV-related problems still have a notable impact on health-related quality of life, even in virally suppressed people living with HIV as a result of taking ART [6] , and this could have a negative impact in their health outcomes [7] .
To address the wellbeing of people living with HIV constitutes a big challenge for healthcare systems [8] . It implies improving the model of care to face the complexity of addressing not only the combined burden of HIV and its comorbidities [4, 9] but also other issues related to the health-related quality of life of people living with HIV [8] . This requires a patient-centered approach that involves patient engagement as well as the widespread use of innovations in chronic care [10] . In this context, having information about the patient's experience can provide relevant information to improve the quality of care [10] [11] [12] . Patient experience is defined as the information that patients provide to facilitate their continued interaction with health and social care professionals and services and their experience of that interaction and its outcomes [10] . Patient experience has been recognized as a central issue in the quality of healthcare delivery to patients along with clinical effectiveness and patient safety across a wide range of disease areas [12] .
The present study is a secondary analysis of broader research that has evaluated the experience of chronically ill patients (diabetes mellitus, HIV, inflammatory bowel disease, and rheumatic diseases) with healthcare. For this purpose, it used the Instrument for Evaluation of the Experience of Chronic Patients (IEXPAC) Questionnaire [10] . This scale is one of the most recent instruments developed, which incorporates a broad notion of integrated care. Results of the principal analysis showed that people living with HIV presented better overall experience with healthcare than patients with other chronic conditions. It also revealed that treatment and clinical care complexity had a negative association with better patient experience. The primary analysis was described elsewhere [13] .
The present analysis aimed to go one step further, analyzing the influence of the different dimensions of patient experience on the healthrelated quality of life of people living with HIV. To our knowledge, hardly any studies have assessed such influence. We also analyzed the role played by the treatment and clinical care complexity of people living with HIV in the relationship between patient experience and health-related quality of life.
METHODS

Study Population and Procedures
We conducted a cross-sectional survey in which 467 people living with HIV participated. They were recruited by convenience sampling. The general inclusion criteria were: HIV? diagnosis, C 18 years, and having multiple morbidities. The present study is part of broader research that evaluated chronically ill patients' experience with healthcare [13] .
HIV care in Spain is provided in tertiary care settings (i.e., public hospitals) through specific HIV clinics within the infectious diseases units. Antiretroviral drugs are dispensed in hospital pharmacies by specialized personnel. Access to the Spanish healthcare system is universal, and almost all patients are treated in hospitals that belong to the public healthcare system. People living with HIV may be attended in a primary care setting for conditions attended in primary care (i.e., non-HIV-related comorbidities). HIV specialists from 25 HIV clinics across Spain collaborated in the recruitment of participants. During their consultations, they explained the goal of the study to the patients and proposed their participation. They requested them to complete the survey voluntarily and anonymously at home and then return it by pre-paid mail.
To minimize selection bias, each physician offered participation in the study to the first 25 consecutive patients attending the clinic routinely, regardless of age, sex, disease severity, or any other criteria. Survey distribution and collection were conducted between May and September 2017. The survey was handed to 627 patients and was returned by 467 patients (response rate of 74.72%).
The Clinical Investigation Ethics Committee of the Gregorio Marañón Hospital of Madrid (Spain) approved the research protocol. The study documentation included printed instructions and information for patients about the anonymous nature of the survey and aggregated data processing, which ensured that patient identification was not possible. As agreed by the Clinical Investigation Ethics Committee, the voluntary return of completed questionnaires was taken as implied consent to participate in the study. No clinical data were collected in this study.
Instrument
The survey contained the following variables: Instrument for Evaluation of the Experience of Chronic Patients (IEXPAC) [10] . It includes 11 items, plus an additional item for recently hospitalized patients. The items refer to the last 6 months, except for the question about hospitalization, which refers to the previous 3 years, and they have a five-option Likert scale response (always, mostly, sometimes, seldom, and never). The first 11 items have a three-factor structure. Factor 1 is called productive interactions and refers to the characteristics and content of interactions between patients and professionals designed to improve outcomes. Factor 2, the new relational model, refers to new forms of patient interactions with the healthcare system, through the internet, or with peers. Finally, factor 3, called patient self-management, refers to individuals' ability to cope with their diseases, manage their self-care, and improve their wellbeing, based on interventions mediated by healthcare professionals. The results of the Spanish validation study of this instrument showed good fit indices (SMRS = 0.05, GFI = 0.96, and CFI = 0.96) and reliability of the factors (PI = 0.91, NRM = 0.90, and PSM = 0.95) [10] .
Health-related Quality of Life Questionnaire (EQ-5D-5L) [14, 15] : The EQ-5D-5L is a standardized generic measure that comprises five dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) with five levels each (no problems, slight problems, moderate problems, severe problems, and extreme problems). The instrument also contains a visual analog scale (EQ-VAS) that records the respondent's self-rated health on a 20-cm vertical scale with end points labeled ''the best you can imagine'' and ''the worst you can imagine.'' We used the validated Spanish version of this measure.
The survey also contains the following variables: (1) complexity of clinical care-number of different physicians seeing the patient and number of different healthcare sites that the patient usually attends; (2) complexity of the patient's treatment-number of different medicines that the patient takes and the number of daily doses of the treatment the patient takes. Finally, the survey collected primary general demographic data (sex, age, educational level, and current occupational status).
The survey can be consulted in the Electronic Supplementary Material of Orozco-Beltrán et al. [13] . All the survey was designed and administered in Spanish.
Data Analysis
First, we performed an exploratory analysis. Next, we analyzed differences in the target variables according to participants' gender and age. Regarding age, we established the cutoff point, generally accepted in HIV, of 50 years to consider the health impact of aging in people living with HIV [4] (group 1 B 49 years, group 2 C 50 years).
Following that, we adopted a predictive model based on correlations between the studied variables and previous results of our research [13] through the partial least squares (PLS) method, using the SmartPLS 3.0 software. The partial least squares is a variance-based technique recommended at an early stage of the theoretical development to test and validate exploratory models [16, 17] . In the partial least squares analysis, the relationships among the studied constructs were analyzed using linear regression in which the loads could be interpreted as standardized beta coefficients. The confidence intervals were based on bootstrapping 500 samples that allowed the generalization of the results and the computation of Student's t for each hypothesis [18] . The coefficient of explained variance (R 2 ) of each endogenous latent variable should be [ 0.10 [19] . No assumption of normality of the distributions is required [20] .
To assess the specific contribution of the variables studied, we first determined whether both measures of health-related quality of life (EQ-5D-5L and EQ-VAS) could be predicted by the factors of the Instrument for Evaluation of the Experience of Chronic Patients. Second, we introduced treatment complexity in the model. Next, we introduced the complexity of clinical care. We assessed the effect sizes of the models tested through the f 2 statistic. Values of 0.02, 0.15, and 0.35 indicate small, medium, and large effects, respectively [17] .
Finally, we evaluated the effect of aging in the model, comparing the final model in the two agespecific groups established (G1 B 49 years, G2 C 50 years). For this purpose, we first conducted the measurement invariance of composite models (MICOM) procedure in PLS. If the results support the measurement invariance, a multigroup analysis could be conducted to compare the path coefficients of the structural model. However, if the measurement invariance is not established, a multigroup analysis is not feasible, and thus it is recommended to analyze the groups separately [21] .
RESULTS
Most participants were male (73.5%). Mean age of the participants was 51.6 (SD = 10.9). A total of 44.3% were working, 34.3% were retired or occupationally disabled, 16.7% were unemployed, and 4.8% had another occupation (student or housework). The majority of the participants had studied primary (42.4%) or secondary education (35.9%), and 21.7% had a university degree.
Correlations Among the Variables Under Study and Differences According to Participants' Characteristics
The descriptive statistics of the variables used in the model, as well as the correlations among the variables, are shown in Table 1 .
Results showed that female patients' selfmanagement score was higher than that of males 
Model Testing
Step 1: The influence of the experience of people living with HIV with healthcare on their health-related quality of life.
The first step was to test whether health-related quality of life could be predicted by the different dimensions of the patient experience (Fig. 1) . Results showed that patient self-management was the only factor that was positively and significantly associated with both healthrelated quality of life measures (EQ-5D-5L: b = 0.34, p \ 0.0001; and self-rated health, EQ-VAS: b = 0.38, p \ 0.0001). The relationship between the productive interactions and the new relational model with the two health-related quality of life measures was nonsignificant, although in the former (productive interactions with health-related quality of life), the path coefficients showed a negative, albeit minimal, direction (productive interactions EQ- Correlations were analyzed using Pearson's coefficients (r) M mean, SD standard deviation, PI productive interactions, NRM new relational model, PSM patient self-management, EQ-5D five dimensions of the Health-Related Quality of Life Questionnaire, EQ-VAS analog visual scale measuring self-rate of health, CT complexity of the treatment, CCC complexity of the clinical care *p \ 0.01; **p \ 0. The model explained more variance in the self-rated health-EQ-VAS (R 2 = 0.16) than that of the EQ-5D-5L (R 2 = 0.09). Summarizing the first step of the model testing, we can conclude that only the dimension of patient-self management positively and significantly predicted people living with HIVs' health-related quality of life.
Step 2: The influence of treatment complexity on health-related quality of life.
In the second step, we introduced treatment complexity into the model (Fig. 2) . Results showed that it was negatively associated with both measures of health-related quality of life (EQ-5D-5L: b = -0.37, p \ 0.0001, and selfrated health (EQ-VAS): b = -0.36, p \ 0.0001). The introduction of treatment complexity in the model increased the amount of explained variance of health-related quality of life, showing a medium effect size in both the explanation of the 5D-5D-5L scale (R 2 = 0.22; f 2 = 0.17) and self-rated health scale (EQ-VAS) (R 2 = 0.29; f 2 = 0.18). Thus, this model had a higher predictive capacity of the people with HIV healthrelated quality of life than the previous one (model tested in Step 1).
Step 3: The influence of the complexity of clinical care on the model.
Finally, we introduced the complexity of clinical care into the model (Fig. 3) . Results showed that it was negatively associated with the productive interactions and patient selfmanagement factors of the patient experience Table 3 . PI productive interactions, NRM new relational model, PSM patient self-management, EQ-5D five dimensions of the Health-related Quality of Life Questionnaire, EQ-VAS analog visual scale measuring self-rate of health (b = -0.21, p \ 0.0001, and b = -0.21, p \ 0.0001, respectively). Complexity of clinical care was also negatively associated with both health-related quality of life measures (EQ-5D-5L: b = -0.37, p \ 0.0001, and self-rated health (EQ-VAS): b = -0.19, p \ 0.0001). Moreover, the negative relationship between the complexity of clinical care and the productive interactions factor led to an increased negative relationship of this factor on the EQ-5D-5L measure of health-related quality of life. The introduction of the complexity of clinical care in the model increased the amount of explained variance of the EQ-5D-5L health-related quality of life measure, showing a medium effect size (R 2 = 0.32, f 2 = 0.17). However, the effect size was weak in the case of self-rated health (EQ-VAS) (R 2 = 0.31, f 2 = 0.03). Thus, this model had a higher predictive capacity of the people with HIV's health-related quality of life than the two previous ones (models tested in step 1 and step 2).
Summarizing the results of the final model, we could observe that patient self-management showed the highest positive relationship with the patient's health-related quality of life. On the contrary, the productive interactions presented a negative relation with the EQ-5D-5L measure of health-related quality of life. Furthermore, the complexity of patients' treatment also predicted their health-related quality of life negatively. Finally, the complexity of clinical care also damaged healthrelated quality of life, both directly and through its negative influence on the productive interactions with healthcare professionals and patient self-management dimensions of the patient experience. The introduction in the model of the complexity of treatment and clinical care increased the predictive capacity of the model. Table 2 displays the total effects of the variables on the health-related quality of life.
For the sake of clarity, only the relationships among the latent variables (inner model) are Table 3 . PI productive interactions, NRM new relational model, PSM patient selfmanagement, EQ-5D five dimensions of the Health-related Quality of Life Questionnaire, EQ-VAS analog visual scale measuring self-rate of health, CT complexity of the treatment Table 3 . PI productive interactions, NRM new relational model, PSM patient self-management, EQ-5D five dimensions of the Health-related Quality of Life Questionnaire, EQ-VAS analog visual scale measuring self-rate of health, CT complexity of the treatment, CCC complexity of the clinical care [17] . Most variables also presented adequate construct reliability and validity. The factor ''new relational model'' had the lowest reliability, although it could be considered adequate, as it had only three indicators [22] . The patient self-management factor showed the lowest value of convergent validity, but it was close to 0.50 [average variance extracted (AVE) = 0.44], a value that can be considered adequate [17] .
Differences According to Age in the Predictive Model
To test whether the model was invariant or equivalent across the established age-specific groups (G1 B 49 years, G2 C 50 years), we first assessed the measured model invariance. Configurational invariance was assumed because constructs were equally parameterized and estimated across groups. Regarding compositional invariance, results of the measurement invariance of the composite model procedure showed that the correlations between the composite scores of the two groups were not significantly \ 1 in most variables except for treatment complexity (permutation p = 0.022). Thus, partial measurement invariance or equivalence cannot be established for this latent variable. Results of the assessment of Consequently, we analyzed the predictive model separately in the two age-specific subsamples. Results showed that the path coefficients among the three factors of the patient experience and both measures of the healthrelated quality of life (EQ-5D-5L and EQ-VAS) were only significant in those people living with HIV C 50 years (Table 3) . Thus, the total effects of these factors of patient experience on healthrelated quality of life were higher in the people living with HIV C 50 years than in those B 49 years (Table 2) , and they were significant only in the older group (p \ 0.05). The highest effect size in this group was the positive relationship between the factor patient selfmanagement and self-rated health (f 2 = 0.16). However, the complexity of treatment and clinical care produced the highest total effects in the people living with HIV B 49 years, and the path coefficients between these variables and the health-related quality of life EQ-5D-5L measure had the highest effect sizes in this group (f 2 = 0.15 and f 2 = 0.23 for the complexity of treatment and the complexity of clinical care, respectively).
DISCUSSION
The present study aimed to analyze the influence of different factors of patients' experience on the health-related quality of life of people living with HIV and the role that the complexity of the treatment and clinical care played in it. Furthermore, it analyzed differences in those relationships according to whether the participants were younger or older than 50 years, which is a suggested cutoff point to consider the health impact of aging in people living with HIV [4] .
Results of the model tested in the total sample showed that patient self-management was the only dimension of patients' experience that positively predicted the health-related quality of life of people living with HIV. Several studies have shown the central role that patient self-management plays in the health and wellbeing of patients living with chronic diseases [23, 24] . Programs of training patients in selfmanagement behaviors led to an improvement of health status, reduction of hospital admissions, and the costs of healthcare [23] . Such training also improves healthy behaviors and health outcomes of people living with HIV [25, 26] .
However, patients' experience itself explained a limited amount of the variance of the health-related quality of life. It is because treatment and clinical care complexity played a relevant role in their relationship. The treatment complexity of people living with HIV had a direct negative association with their healthrelated quality of life. Previous studies have found a negative influence of complex treatments in people living with HIV wellbeing [27, 28] and the risks of polypharmacy in aging people living with HIV who are suffering comorbidities [4] . The complexity of patients with HIV's clinical care also had a direct negative influence on their health-related quality of life. However, it also damaged their health-related quality of life indirectly through its negative effects on the productive interactions of people living with HIV with healthcare professionals and their health self-management. The complexity of clinical care might make interactions with healthcare providers negative or unproductive and hinder the self-management of their health. Previous results from our broader research showed that some variables related to the complexity of clinical care were negatively associated with all factors of the different chronic patients' experience [13] . Our secondary analysis showed their impact not only on HIV patients' experience but also on their health-related quality of life.
Our results also showed that the effects of the dimensions of patient experience on their health-related quality of life were higher in people living with HIV older than 50 years than those who were younger. The highest positive influence of patient self-management on health-related quality of life occurred in this group. Moreover, the new relational model influenced the health-related quality of life in those older than 50 years but not of the younger patients. The management of the HIV aging process implies an increased challenge for both patients and healthcare providers [29, 30] . According to our results, it seems that patients' experience with healthcare professionals is particularly relevant in the management of the aging process of people living with HIV. There is currently a scientific debate on the need for a new healthcare model that responds effectively to the emerging challenges related to the aging process of people living with HIV [4, 31] . Lessons learned from the management of other chronic diseases point out the need to move toward patient-centered models such as the Chronic Care Model [24] .
Results also showed that, although people living with HIV older than 50 years presented higher scores in the complexity of treatment and clinical care than those younger than 50, such complexity produced a higher negative effect on the health-related quality of life of the latter group (B 49 years). A possible explanation for this increased burden in younger patients' health-related quality of life may be that they have less mastery and skills to deal with such complexity and they are less resilient than the older patients, who had probably lived more time with HIV and other comorbidities. Mastery, acceptance of illness, self-care, and illness perception were some of the factors found to be related to resilience in the physically ill, and some studies found that old age was related to being more adaptive and resilient [32] .
Our study has some limitations: first, those derived from its cross-sectional nature, which precludes establishing causal relationships among the variables under study. Future studies should confirm our results using a longitudinal approach. Also, we did not perform probabilistic sampling, but the consecutive inclusion of patients aimed to reduce selection bias. Moreover, because the survey was anonymous, we could not know the profiles of the people living with HIV who did not return the survey. A larger sample is necessary to strengthen the comparisons according to age and generalize the results. Besides, time since HIV diagnosis was not collected because it was neither the primary nor secondary objective of the study, and the research team decided to collect the minimum data to facilitate quick answers of the participants and thus get a large sample. However, 
CONCLUSION
In summary, the present study found that patients' experience with healthcare was associated mainly with the health-related quality of life of aging of people living with VIH. Patient self-management showed the highest positive relation with their health-related quality of life. Treatment and clinical care complexity played an important role in damaging patients' experience and their health-related quality of life. The World Health Organization recognizes patient self-management as the best practice to improve clinical care and outcomes in chronic patients [33] . Our results highlight the need for more integrated care for people living with HIV because it has been shown to have beneficial effects on several chronic health-related outcomes and on the quality of patient care [34] . Authorship. All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.
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